European Association of Urology (EAU21) Virtual Congress

Obesity may influence survival in metastatic castration-resistant prostate cancer

Roshini Claire Anthony, 20210908180001

The obesity paradox, where obesity appears to confer a protective effect, was noted in metastatic castration-resistant prostate cancer (CRPC), with improved survival outcomes among obese patients with metastatic CRPC, according to a study from EAU21.

Outcomes of active surveillance for prostate cancer may vary with age

Roshini Claire Anthony, 20210907180001

The benefits of active surveillance for prostate cancer appear to be greater in men diagnosed with low-risk prostate cancer at an older age, according to a study from Sweden.

MRI-targeted biopsy + new risk score cuts unnecessary biopsies in prostate cancer

Elvira Manzano, 20210907000000

An MRI-targeted biopsy* plus a new risk score cuts unnecessary biopsies by half in men with positive MRI results and elevated PSA** levels in the STHLM3-MRI study. This benefit comes without missing clinically significant cancers, experts report at EAU 2021.

High urine cotinine levels may signal bladder cancer recurrence

Roshini Claire Anthony, 20210826180001

High levels of cotinine in the urine of smokers who have undergone resection for non-muscle invasive bladder cancer (NMIBC) could be a sign of cancer recurrence, according to a study from Lebanon presented at EAU21.

AbobotulinumtoxinA cuts incontinence episodes in patients with NDOI

Audrey Abella, 20210820100000

In individuals with neurogenic detrusor overactivity incontinence (NDOI) who were regularly undergoing clean intermittent catheterization, significant reductions of urinary incontinence episodes were seen following treatment with abobotulinumtoxinA (aboBoNT-A), according to a pooled analysis of two CONTENT studies presented at EAU 2021.

Botulinum toxin type A may reduce incontinence episodes

Audrey Abella, 20210819100000

In a systematic review and meta-analysis of randomized controlled trials (RCTs) presented at EAU 2021, the use of botulinum toxin (BTX) type A in individuals with neurogenic detrusor overactivity (NDO) and idiopathic overactive bladder (iOAB) led to a reduction in incontinence episodes.

MV140 bacterial vaccine reduces UTI frequency in women

Elaine Soliven, 20210818000000

The sublingual bacterial vaccine MV140 reduces the number of recurrent urinary tract infections (UTIs) in women, according to a European study presented at EAU21.

Testosterone therapy in hypogonadal men: Good for the heart and kidneys?

Elvira Manzano, 20210811000000

Testosterone replacement therapy (TRT) reduces the risks of major adverse cardiovascular events (MACE) and deaths in hypogonadal men, according to long-term data reported at EAU21.

Has COVID-19 changed the pathological outcomes in prostate cancer?

Elvira Manzano, 20210805000000

The likelihood of pT3* or higher tumours and node-positive disease found at the time of radical prostatectomy (RP) for prostate cancer (PCa) was greater during the COVID-19 pandemic than it was before, an expert reported at EAU21.